WASHINGTON — Chalk one up for the pharmaceutical lobby. The U.S. drug industry fended off price curbs and other hefty restrictions in President Barack Obama's health care law even as it prepares for plenty of new business when an estimated 32 million uninsured Americans gain health coverage. To be sure, the law also levies taxes and imposes other costs on pharmaceutical companies, leaving its final impact on the industry's bottom line uncertain.
Stories Related to Big Pharma Wins Big With Health Care Reform Bill
The Huffington Post News Editors, Huffington Post
Mon, 03/29/2010 - 9:50am
RELATED ARTICLES
- Professor explains wild airline rant: In-flight cigarette was ‘revolutionary’ act of ‘civil disobedience’
A Penn State professor was arrested over the weekend in a bizarre videotaped incident that went viral. Karen Halnon, who teaches sociology at the university’s Abington campus, was flying from Nicaragua to Miami when she lit up a cigarette and ranted about Venezuela and President Barack Obama. More - Republicans to back Obama's student loan plan
House Republicans are willing to give President Barack Obama a rare win, the chairman of the Education and Workforce Committee said Thursday in outlining a deal that would let college students avoid a costly hike on their student loans. More - Obama to open middle-class jobs, opportunity tour
Aiming to show he's still focused on creating jobs, President Barack Obama is beginning a series of quick trips around the country to resurrect ideas from his State of the Union address that became overshadowed by the intense debates over gun control, immigration and automatic spending cuts. More - GOP boycotts health care advisory board
House and Senate Republican leaders told President Barack Obama Thursday that they will refuse to nominate candidates to serve on an advisory board that is to play a role in holding down Medicare costs under the new health care act. More - US medicine spending shows rare dip
Total U.S. spending on prescription medicines declined last year, a first in more than half a century. The dip was 1 percent, to $325.8 billion — a 3.5 percent drop after accounting for population growth and economic expansion, according to the IMS Institute for Healthcare Informatics. More
BING NEWS:
- Big Pharma Q1 earnings roundup: Novo, Moderna and Regeneron report
Building on the continued momentum behind its GLP-1 drugs, the pharma company’s parent company, Novo Holdings, announced a deal in early February to buy contract drug manufacturer Catalent in a deal ...
05/2/2024 - 4:54 am | View Link - AAMC study examines the impact of health care consolidation in states
The top three large-group insurers control an average of 82.2% of the market share in each state, nearly twice the combined average market share of each state’s largest health systems, according to a ...
05/1/2024 - 9:31 am | View Link - Health care M&A: Pharma makes moves, hospitals consolidate, scrutiny grows
M&A activity among health care service providers likely will remain soft over the next 12 to 18 months, with only a modest rebound from recently depressed levels.
04/23/2024 - 1:00 pm | View Link - An Overview of Health Care and Pharmaceutical Trends, 2023-2024
Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and ...
04/19/2024 - 8:10 am | View Link - What to Know About Osteoarthritis of the Big Toe (Hallux Rigidus)
“Hallux rigidus” means “stiff big toe.” This term refers to a type of osteoarthritis that develops when the cartilage in the main joint of your toe has been damaged or worn down, causing ...
04/16/2024 - 1:01 pm | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more